Bristol-Myers Squibb Co (NYSE:BMY)

54.80
Delayed Data
As of Jun 15
 +1.17 / +2.18%
Today’s Change
49.96
Today|||52-Week Range
70.05
-10.57%
Year-to-Date
Wall Street Low Friday
Jun 15 / GuruFocus News - Paid Partner Content
ASCO Ends: Winners & Losers at the Key Cancer Research Event
Jun 06 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Bristol Myers, Merck, Roche, Lilly and AbbVie
Jun 11 / Zacks.com - Paid Partner Content
Nektar (NKTR) and Bristol-Myers Present Data on Cancer Study
Jun 05 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: MRK Impresses at ASCO, LLY Gets FDA Nod for Olumiant
Jun 08 / Zacks.com - Paid Partner Content
Bristol-Myers (BMY) Reports Data from CheckMate-214 Study
Jun 05 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close53.63
Today’s open54.14
Day’s range53.86 - 54.81
Volume14,496,733
Average volume (3 months)8,635,832
Market cap$85.0B
Data as of 4:01pm ET, 06/15/2018

Growth & Valuation

Earnings growth (last year)-76.98%
Earnings growth (this year)+12.76%
Earnings growth (next 5 years)+10.60%
Revenue growth (last year)+6.94%
P/E ratio96.1
Price/Sales4.87
Price/Book7.20

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline-0.50-1.19%
NVONovo Nordisk+0.19+0.43%
CELGCelgene-0.31-0.40%
ABTAbbott Laboratories-0.05-0.08%
Data as of 4:15pm ET, 06/15/2018

Financials

Next reporting dateJuly 26, 2018
EPS forecast (this quarter)$0.86
Annual revenue (last year)$20.8B
Annual profit (last year)$1.0B
Net profit margin4.85%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Giovanni Caforio
CFO, EVP &
Head-Global Business Operations
Charles A. Bancroft
Corporate headquarters
New York, New York

Forecasts